Iron supplement D — Competitive Intelligence Brief

Iron supplement D (Iron supplement D) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

phase 3 Iron supplement Hematology Small molecule

Target snapshot

Iron supplement D (Iron supplement D) — Tanabe Pharma Corporation. Iron supplement D replenishes iron stores to treat or prevent iron deficiency anemia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iron supplement D TARGET	Iron supplement D	Tanabe Pharma Corporation	phase 3	Iron supplement
Daily Ferrous Sulfate	Daily Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement
ARM A : IV iron + epoietin zeta	ARM A : IV iron + epoietin zeta	Centre Francois Baclesse	marketed	Iron supplement + Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
F (ferrous sulphate)	F (ferrous sulphate)	Abdelwahed, Mai Mahmoud Mohamed, M.D.	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Ferrous sulphate	Ferrous sulphate	University of Lausanne	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Sucrosomial Iron	Sucrosomial Iron	Cardiochirurgia E.H.	marketed	Iron supplement
Erythropoietin subcutaneously and Iron intravenously	Erythropoietin subcutaneously and Iron intravenously	Catharina Ziekenhuis Eindhoven	marketed	Erythropoiesis-stimulating agent combined with iron supplement	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class